GALECTO BIOTECH ApS: Financial statements 2022
CVR: 34878366
Source: annual report 2022, Danish Business Authority
01/01/2022 – 31/12/2022
GALECTO BIOTECH ApS (CVR 34878366) has filed annual accounts for 2022. In 2022, the company reported a gross profit of EUR 12,287,141 and a net result of EUR 818,741 compared with EUR 764,793 the year before. That is an increase of 30.6% compared with the year before. Equity in the 2022 report amounted to EUR 7,394,015. The solvency ratio was 74.7%. The company had 36 employees in the financial year.
- Gross Profit
- EUR 12,287,141
- Profit/Loss
- EUR 818,741
- Equity
- EUR 7,394,015
- Total Assets
- EUR 9,898,978
- Employees
- 36
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2022 | - | 12.3 mio. EUR | 819 t. EUR | 7.4 mio. EUR | 36 |
| 2021 | - | 9.4 mio. EUR | 765 t. EUR | 3.7 mio. EUR | 29 |
| 2020 | - | 4.9 mio. EUR | 214 t. EUR | 2.9 mio. EUR | 16 |
| 2019 | - | 2.4 mio. EUR | 324 t. EUR | 2.7 mio. EUR | 11 |
| 2018 | - | -2.6 mio. EUR | -3.7 mio. EUR | -12.8 mio. EUR | 5 |
Official annual report
Keep an eye on GALECTO BIOTECH ApS
Get notified instantly about new financial statements, ownership changes, management changes and status changes.
Set up monitoringEvents in 2022
GALECTO BIOTECH ApS has published its annual report for 2021. Gross profit came to DKK 9,406,910, and the net result was DKK 764,793.
About GALECTO BIOTECH ApS
GALECTO BIOTECH ApS is a Danish company of the type Anpartsselskab based in Frederiksberg, founded in 2012. The company is registered under the industry Forskning og eksperimentel udvikling inden for naturvidenskab og teknik. The management consists of Garrett Michael Winslow. The company is owned by Galecto Biotech AB. The company has 3 employees (2018). In 2025, the company reported a gross profit of EUR 1,039,275 and a net result of EUR -709,079 compared with EUR 310,297 the year before. Equity in the 2025 report amounted to EUR 7,844,625.